What Medications You Shouldn't Take with Melatonin?

Melatonin is sold without a prescription in the US and Canada, which leads many people to assume it has no meaningful drug interactions. It does. Drugs.com's clinical interaction database lists 354 known drug interactions with melatonin — 5 of them classified as major. Understanding which medications require caution before you add melatonin to your routine is not optional; for patients on blood thinners, antidepressants, or certain blood pressure drugs, it is a genuine safety matter.

Table of Contents

1. How Melatonin Is Metabolised — and Why It Matters for Drug Interactions
2. Antidepressants: The Highest-Risk Category
3. Blood Thinners: Warfarin and Bleeding Risk
4. Blood Pressure Medications: A Two-Way Problem
5. Sedatives and CNS Depressants: Additive Drowsiness
6. Diabetes Medications: Blood Sugar Monitoring Required
7. Immunosuppressants and Anticonvulsants
8. BioAbsorb Liposomal Melatonin — Why Dose Precision Matters for Drug Safety
9. Frequently Asked Questions
10. Conclusion
11. Research References

1. How Melatonin Is Metabolised — and Why It Matters for Drug Interactions

Most supplement users think about drug interactions in simple terms: one drug blocks or amplifies another. For melatonin, the mechanism is more precise. Research published in the Journal of Clinical Psychopharmacology confirmed that melatonin is almost exclusively broken down by the liver enzyme CYP1A2, with minor contributions from CYP2C19. This single metabolic pathway is the root cause of the majority of melatonin's clinically meaningful drug interactions.

When another drug either inhibits or competes with CYP1A2, two things can happen: melatonin levels in the bloodstream rise (because it is not being cleared quickly enough), or the co-administered drug's levels rise (because melatonin is competing for the same enzyme). Both scenarios can push pharmacological effects beyond their intended range. In vitro studies using human liver preparations confirmed that only potent CYP1A2 inhibitors — not weak or moderate ones — produce clinically significant melatonin accumulation at typical supplement doses.

This enzyme-level understanding is practically important: it tells you which drug categories to scrutinise most carefully. Any medication your doctor describes as a "CYP1A2 inhibitor" or a "CYP1A2 substrate" belongs on your pharmacist's review list before you add melatonin. The interactions below are organised not alphabetically, but by their clinical significance — beginning with the categories that carry the greatest evidence of real-world risk.

2. Antidepressants: The Highest-Risk Category

Antidepressants represent the most documented and mechanistically understood category of melatonin interactions. A 2023 clinical review in Clinical Interventions in Aging identified fluvoxamine (Luvox) as producing the most dramatic interaction — capable of increasing peak serum melatonin concentrations by a factor of 2.8 to 12, depending on the individual. This is not a subtle pharmacokinetic nudge; it means that a 1.5mg melatonin dose could behave like 4mg to 18mg in someone taking fluvoxamine. Excessive drowsiness, morning grogginess, and headache are the most likely results.

The mechanism is well-established: a 2000 study in the European Journal of Clinical Pharmacology demonstrated that fluvoxamine is a potent CYP1A2 inhibitor. When this enzyme is blocked, melatonin cannot be cleared at its normal rate, and serum levels accumulate. Crucially, the same study found that citalopram — another SSRI — had no measurable effect on melatonin levels, because it does not inhibit CYP1A2. Not all antidepressants carry the same risk, and the difference is enzymatic, not drug class-wide.

For patients on antidepressants, the practical guidance differs by drug. Nortriptyline (a tricyclic), fluvoxamine, and certain other SSRIs warrant the most caution when considering melatonin. A published case report documented severe sedation in a patient taking oxycodone, citalopram, and nortriptyline together with melatonin — a polypharmacy scenario that highlights why interaction checking is not sufficient one drug at a time. Anyone on an antidepressant should review their specific medication with a pharmacist before starting melatonin.

• Highest risk: Fluvoxamine (Luvox) — CYP1A2 inhibitor, can raise melatonin up to 12x
• Moderate risk: Nortriptyline, some other tricyclics — CYP2C19 inhibition
• Lower (but monitor): Fluoxetine, citalopram — may modestly raise melatonin in some individuals
• Serotonin syndrome risk: SSRIs combined with melatonin have been associated with rare cases of serotonin syndrome — seek medical care immediately if you experience confusion, high fever, or sweating

3. Blood Thinners: Warfarin and Bleeding Risk

The interaction between melatonin and warfarin (Coumadin) is one of the most clinically important for patients on long-term anticoagulation therapy. A case series of 10 patients evaluated at Massachusetts General Hospital found that concurrent melatonin and warfarin use increased both INR (International Normalized Ratio) and prothrombin time in the majority of patients. Using the Drug Interaction Probability Scale, 6 patients had a possible interaction, and 2 had a probable interaction — though no active bleeding events were recorded during the study period.

The mechanism involves melatonin's independent effect on coagulation. Research published in a 2023 PMC review found that a single 3mg oral dose of melatonin reduced plasma levels of coagulation factors FVIII:C and Fibrinogen within 60 minutes — independent of any other medication. When this coagulation-reducing effect is layered on top of warfarin, the combined anticoagulant burden increases. For patients whose INR is already carefully calibrated, any disruption to that balance carries real consequences.

Warfarin therapy demands a stable pharmacological environment. Patients are advised to maintain consistent vitamin K intake, avoid alcohol, and disclose every supplement to their prescribing physician — yet melatonin's OTC status means it is frequently overlooked. The practical recommendation is clear: if you are on warfarin or any other anticoagulant, discuss melatonin with your prescriber before starting it, and arrange additional INR monitoring during the first weeks of concurrent use. Drugs.com's warfarin-melatonin interaction profile recommends dose adjustment or more frequent monitoring for patients combining these two agents.

4. Blood Pressure Medications: A Two-Way Problem

The relationship between melatonin and blood pressure medications involves two distinct and opposing dynamics — which is what makes this category particularly difficult to predict without clinical monitoring. On one side, melatonin can interfere with nifedipine, a calcium channel blocker used to treat hypertension. A clinical study found that 5mg of melatonin taken for four weeks alongside nifedipine raised systolic blood pressure by 6.5 mmHg and diastolic pressure by 4.5 mmHg — a clinically meaningful increase that effectively reduced the medication's efficacy. The proposed mechanism is competition at the calcium channel receptor.

On the other side, melatonin taken with other blood pressure-lowering agents — particularly in older adults — can produce the opposite problem: additive hypotension. Mayo Clinic's drug reference notes that melatonin might worsen blood pressure in people taking blood pressure medications — without specifying directionality, because the effect varies by medication class. Older adults may be especially susceptible to blood-pressure-lowering effects from melatonin taken independently, and adding antihypertensive medications to this picture introduces unpredictable effects.

• Nifedipine (Procardia): Melatonin reduces its effectiveness — blood pressure may rise
• Other antihypertensives: Melatonin may have an additive effect — blood pressure may drop too low
• Older adults: Particularly vulnerable to blood pressure changes with melatonin; start at the lowest effective dose (0.25–0.5mg)

If you take any blood pressure medication, your prescriber should know you're taking melatonin. They may want you to monitor your blood pressure more frequently during the initial weeks, and to report any readings that fall outside your target range — high or low.

5. Sedatives and CNS Depressants: Additive Drowsiness

Melatonin's sleep-promoting properties make it a logical complement to sedative medications in many people's minds — but this intuition points directly at the interaction risk. When melatonin is combined with central nervous system (CNS) depressants, their sedative effects add together, not substitute for each other. Clinical pharmacists at GoodRx identify the relevant categories as: Z-drugs (zolpidem/Ambien, zaleplon/Sonata), benzodiazepines (alprazolam/Xanax, diazepam/Valium, lorazepam/Ativan), opioids, antihistamines (diphenhydramine/Benadryl), sedating antidepressants (trazodone, amitriptyline), and alcohol.

The clinical concern is not merely feeling sleepier than intended — though next-day grogginess and impaired driving ability are real risks. At the extreme end, a published case report documented severe sedation in a patient taking oxycodone alongside citalopram, nortriptyline, and melatonin — a scenario that illustrates how polypharmacy compounds individual interaction risks. The FDA has issued black box warnings specifically against combining opioids with other CNS-depressant medications due to risk of respiratory depression.

Practically, if you take melatonin only at bedtime for sleep, the additive sedation with nighttime medications is generally less concerning than during-the-day dosing. However, the next-morning hangover effect — residual grogginess that affects driving and cognitive function — is a documented concern, especially with higher melatonin doses (5–10mg). This is one reason starting with the lowest effective dose, around 0.5–1.5mg, is clinically sensible when any CNS-active medication is in the picture.

6. Diabetes Medications: Blood Sugar Monitoring Required

Melatonin's relationship with glucose metabolism adds complexity for people managing type 1 or type 2 diabetes. Research indicates that melatonin can lower blood glucose and improve insulin sensitivity — an effect that sounds beneficial in isolation, but becomes a safety concern when layered on top of insulin or oral hypoglycemic drugs. Clinical reviews of melatonin and glucose metabolism note that supplementation has been associated with significant reductions in glucose and insulin levels in some studies. For someone already on a glucose-lowering medication, this additive effect could push blood sugar to hypoglycemic levels.

The interaction is not straightforward. Other studies have found conflicting results regarding melatonin's effect on blood glucose, and the direction of the effect may depend on timing, dose, individual genetics, and baseline glucose status. The NCCIH advises that patients with diabetes who wish to use melatonin should do so under medical supervision and monitor their blood glucose carefully, particularly when first starting. This is not a contraindication — it is a monitoring requirement.

The practical protocol for diabetic patients considering melatonin is to discuss it with their diabetes care team, start at the lowest effective dose, monitor blood glucose more frequently for the first 2–4 weeks, and have fast-acting glucose (tablets or gel) available as a precaution. Starting at 0.5mg — rather than the 5–10mg products common in retail stores — gives the most conservative safety margin while still providing a measurable sleep signal.

7. Immunosuppressants and Anticonvulsants

Two additional medication categories require attention — immunosuppressants and anticonvulsants — though the evidence base for each is somewhat different in character. For immunosuppressants, the concern is mechanistic: melatonin has demonstrated immune-stimulating properties in multiple studies. Mayo Clinic notes that melatonin can stimulate immune function and interfere with immunosuppressive therapy — a meaningful concern for organ transplant recipients or patients with autoimmune conditions whose immune systems are deliberately suppressed. If melatonin stimulates immune activity in these patients, it works directly against the medication's therapeutic purpose.

For anticonvulsants, the picture is more nuanced. Some clinical research — primarily in children with neurological impairment — suggests that melatonin might theoretically reduce the effectiveness of anticonvulsant medications or increase seizure frequency in susceptible individuals. NCCIH specifically recommends that people with epilepsy taking anticonvulsants be under medical supervision if they choose to use melatonin. This evidence is more limited and the signal is not established in adults, but the risk-benefit equation for someone with controlled epilepsy warrants careful discussion with a neurologist.

Other medications worth noting include oral contraceptive pills, which may raise melatonin levels in the body — a lower-stakes interaction, but one that may explain heightened drowsiness or side effects in some users. Caffeine interacts with melatonin via the same CYP1A2 pathway and can more than double melatonin plasma levels in some individuals, though this is less clinically significant given the timing typically separates the two compounds. Certain antibiotics (fluoroquinolones, erythromycin) may also elevate melatonin levels, though antibiotic courses are typically short enough that the effect is transient and unlikely to require dose adjustment in otherwise healthy individuals.

8. BioAbsorb Liposomal Melatonin — Why Dose Precision Matters for Drug Safety

Every clinician recommendation for melatonin in the context of drug interactions includes the same underlying principle: use the lowest effective dose. This is not generic caution — it is mechanistically grounded. The higher the melatonin dose, the more pronounced the coagulation effects, the greater the blood-pressure displacement with nifedipine, and the larger the sedation burden when combined with CNS depressants. Dose precision is not a preference; it is the primary lever for managing interaction risk.

This is where BioAbsorb Liposomal Liquid Melatonin offers a practical advantage. Unlike fixed-dose tablets (typically 3–10mg), BioAbsorb's graduated dropper delivers 1.5mg per full 1ml dose — and allows ~0.25mg increments. A patient on warfarin who wants to try melatonin at the most conservative therapeutic dose (0.5mg or even lower) can do so precisely, rather than approximating by cutting a 3mg tablet. For patients with drug interactions on their radar, this kind of titratability is clinically meaningful.

BioAbsorb's liposomal delivery technology achieves 80–95% bioavailability compared to 15–20% for standard melatonin tablets. For drug interaction purposes, this matters because a higher-bioavailability formulation produces a more predictable and consistent blood level — there is less variability in what actually reaches the bloodstream. At $29.99 for 100ml (100 servings), it is manufactured in a GMP-certified, Health Canada-approved facility, is non-GMO, vegan, and gluten-free, and every batch is third-party tested with COAs available on request. For individuals who need melatonin but are managing a complex medication profile, a precisely dosed, high-bioavailability formulation reduces guesswork in an area where guesswork has consequences.

Frequently Asked Questions

Can I take melatonin if I'm on antidepressants?

It depends entirely on which antidepressant. Fluvoxamine (Luvox) is the highest-risk antidepressant for melatonin interaction, capable of increasing blood melatonin levels up to 12-fold due to CYP1A2 enzyme inhibition. Nortriptyline carries moderate risk. Citalopram and many other SSRIs pose lower risk but should still be reviewed. Your pharmacist can identify whether your specific antidepressant is a CYP1A2 inhibitor and advise on whether melatonin is safe at a low dose.

Is it safe to take melatonin with blood pressure medication?

Not without first consulting your prescriber. Melatonin can reduce the effectiveness of nifedipine, potentially raising your blood pressure. With other antihypertensives, melatonin may have an additive lowering effect, causing blood pressure to drop too low. Mayo Clinic recommends informing your doctor before combining melatonin with blood pressure drugs and monitoring your blood pressure more frequently during initial use.

Can melatonin increase my bleeding risk if I'm on warfarin?

Yes — there is documented clinical evidence of this interaction. Melatonin has mild anticoagulant properties of its own, and a case series of 10 patients found that melatonin raised INR and prothrombin time in most individuals taking warfarin. If you are on warfarin, discuss melatonin use with your prescriber and arrange more frequent INR monitoring if you proceed.

Is it okay to take melatonin with a sleeping pill?

Combining melatonin with prescription sleep medications — Z-drugs like zolpidem (Ambien) or benzodiazepines like lorazepam — can produce additive sedation, next-day grogginess, and impaired driving ability. The concern intensifies with opioids, where the FDA has issued black box warnings about combining CNS depressants. If you need melatonin for sleep and are already prescribed a sedative, discuss this with your prescriber rather than stacking them independently.

Does melatonin interact with birth control pills?

Oral contraceptive pills can raise melatonin levels in the body. This means you may experience stronger sedative effects from a given melatonin dose than you'd expect. The practical implication is to start at the lowest effective dose — 0.25–0.5mg — and assess your response before increasing. This interaction is generally considered low-risk but worth knowing about.

What should I do before taking melatonin if I take multiple medications?

Bring your complete medication list — including all prescription drugs, OTC medications, and supplements — to your pharmacist. Pharmacists have access to comprehensive drug interaction databases and can identify CYP1A2 and CYP2C19 pathway conflicts that your physician may not have flagged. NCCIH specifically recommends this step for anyone on medications before starting melatonin, and it takes under 5 minutes.

Conclusion

Melatonin's OTC status does not make it interaction-free. With 354 documented drug interactions — 5 of them major — it is one of the more pharmacologically active supplements in common use. The highest-priority categories to review are antidepressants (especially fluvoxamine), blood thinners (warfarin), blood pressure medications (particularly nifedipine), sedatives, diabetes drugs, immunosuppressants, and anticonvulsants. For anyone navigating these medication classes, starting with a precisely dosed, low-dose melatonin formulation like BioAbsorb Liposomal Liquid Melatonin — and reviewing your full medication list with a pharmacist first — is the safest path to adding melatonin to your routine.

Research References

1. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects — an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. European Journal of Clinical Pharmacology, Vol. 56 (2000). Foundational clinical trial establishing CYP1A2 as the primary melatonin metabolism pathway and demonstrating that fluvoxamine — but not citalopram — significantly elevates serum melatonin by enzyme inhibition.
2. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. Journal of Clinical Psychopharmacology, Vol. 21 (2001). In vitro human liver microsome study confirming that melatonin is almost exclusively metabolised by CYP1A2; fluvoxamine inhibited this pathway at a Ki of 0.02 μM, while fluoxetine, paroxetine, citalopram, and imipramine showed minimal inhibitory effect.
3. Evaluation of the Potential Drug Interaction of Melatonin and Warfarin: A Case Series. Life Science Journal, Vol. 13, No. 6 (2016). Ten-patient case series at Massachusetts General Hospital finding that concurrent melatonin and warfarin raised INR and prothrombin time in most patients, supporting a clinically significant anticoagulation interaction requiring monitoring.
4. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review. CNS Drugs, Vol. 33 (2019). Systematic review of 50 controlled clinical studies finding that cardiovascular and endocrine interactions — including blood pressure and glucose effects — are modulated by dose, timing, and concurrent antihypertensive medications.
5. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. Clinical Interventions in Aging, Vol. 18 (2023). Peer-reviewed clinical review documenting that fluvoxamine increases peak melatonin concentrations by 2.8–12x, that nifedipine combined with 5mg melatonin raised systolic BP by 6.5 mmHg, and that antidepressant polypharmacy compounds sedation risk.
6. Chronic Administration of Melatonin: Physiological and Clinical Considerations. Frontiers in Endocrinology (2023). Narrative review confirming that 3mg oral melatonin reduces coagulation factors FVIII:C and Fibrinogen within 60 minutes, and summarising evidence for interactions with nifedipine, immunosuppressants, and anticoagulants.
7. Melatonin: What You Need to Know. National Center for Complementary and Integrative Health — NIH (2022). Federal health authority overview of melatonin safety and interaction categories; recommends medical supervision for patients with epilepsy or those taking blood thinners.
8. Melatonin Drug Information. Mayo Clinic. Authoritative clinical drug reference summarising key interaction categories including blood pressure drugs, CNS depressants, diabetes medications, CYP enzyme substrates, immunosuppressants, and anticonvulsants.
9. Melatonin Interactions Checker. Drugs.com (2025). Clinical database documenting 354 known drug interactions with melatonin, including 5 major interactions, 340 moderate interactions, and 3 disease interactions, sourced from FDA-approved labelling and clinical literature.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.